Tonix Pharmaceuticals Holding Corp. (TNXP) NASDAQ

19.44

+0.5(+2.64%)

Updated at May 09 10:14AM

Currency In USD

Valuation

Market Cap24.28M
Enterprise Value-66.37M
P/E Ratio-0
PEG Ratio0
Price/Sales Ratio13.25
Price/Book Ratio0
Enterprise/Revenue3.99
Enterprise/EBITDA-0.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-12.88
Operating Margin-7.7

Management Effectiveness

Return On Assets-0.8
Return On Equity-1.43

Income Statement

Revenue10.09M
Revenue/Share445.95
Gross Profit2.33M
EBITDA-71.73M
Net Income-130.04M
Diluted EPS-176.6

Balance Sheet

Total Cash98.78M
Total Cash/Share4,363.86
Total Debt5.3M
Total Debt/Equity0.04
Current Ratio6.5
Book Value Per Share6,165.58

Price History

52-Week Change-96.66
52-Week High672
52-Week Low6.76
Moving Average 50 Days16.96
Moving Average 200 Days23.28

Statistics

Average Volume1.31M
Shares Outstanding6.88M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateFebruary 05, 2025